InvestorsHub Logo

asmarterwookie

04/27/13 11:48 AM

#120368 RE: investingdog #120366

IMHO..the reason is because we are under $5 a share. the only reason we are below five dollars a share is because of the dose switching.

wook

biopharm

04/27/13 2:29 PM

#120386 RE: investingdog #120366

The PPS is low because the major players for whatever reasons apparently give it a very low probability of becoming a SOC at this point.



The only major players involved are those that are part of the sabotage planning and execution of those plans.... due to those major players remains the reason why we sit below $5 as well as the keeping the lid on the stock price due to these major players.

These major players = the opposition against Bavi that wanted to buy Peregrine for pennies on the dollar are soo frustrated right now because Peregrine has the leverage big time going into ASCO. Retail Investors that know whats going on are bought and standing by.... so there are no other "MAJOR" players until we hit $3.. $4... and $5 .. once we move into that territory then the long "MAJOR" players can buy in but until that time... the only major players involved are the opposition keeping the price down.

just see how carboat opened up an ihub account just hours after Black Monday and what does he post 1st? -- Carboats 1st post hours after Black Monday These are the facts for all to see and these are the reasons why many attack this stock.

They want to hide my posts on Peregrines $4B Market Cap is coming soon right here

They also want to hide my posts of why the insiders have set up stock options in Dec of 2012... not April of 2013.... but it just may have been too late. Carboat said insiders are not buying? They don't need to buy because of All these options they have right here!!... gives them the right to buy the stock at $1.18

They also want to hide the fact that their buddies Carboat, frustrated, camatail, Biochica and neutrally decieving others.. : ) they hide it well.... are trying to downplay whats about to happen to Peregrine within the next 45 days.

FDA decisions are coming.... 1st line NSCLC MOS is a coming... and positive indications gives us standard of care... which means a "conservative" market cap of $4 Billion. Anything else... breast cancer results... pancreatic... is icing on the cake.

GLTA!